Psychemedics PRUDENTIAL Bond

PMD Stock  USD 2.67  0.06  2.30%   
Psychemedics holds a debt-to-equity ratio of 0.364. . Psychemedics' financial risk is the risk to Psychemedics stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

Psychemedics' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Psychemedics' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Psychemedics Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Psychemedics' stakeholders.
For most companies, including Psychemedics, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Psychemedics, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Psychemedics' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
2.5793
Book Value
1.149
Operating Margin
(0.19)
Profit Margin
(0.22)
Return On Assets
(0.16)
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
View Bond Profile
Given the importance of Psychemedics' capital structure, the first step in the capital decision process is for the management of Psychemedics to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Psychemedics to issue bonds at a reasonable cost.
Popular NamePsychemedics PRUDENTIAL FINL INC
SpecializationHealth Care Equipment & Services
Equity ISIN CodeUS7443752057
Bond Issue ISIN CodeUS744320AY89
S&P Rating
Others
Maturity DateOthers
Issuance DateOthers
Coupon3.905 %
View All Psychemedics Outstanding Bonds

Psychemedics Outstanding Bond Obligations

US744320BH48US744320BH48Details
US744320BF81US744320BF81Details
PRU 6 01 SEP 52US744320BK76Details
PRU 5125 01 MAR 52US744320BJ04Details
PRUDENTIAL FINL INCUS744320BA94Details
Dana 575 percentUS235822AB96Details
US744320AV41US744320AV41Details
PRUDENTIAL FINL INCUS744320AY89Details
US744320AW24US744320AW24Details
PRUDENTIAL FINL INCUS74432QAC96Details
Boeing Co 2196US097023DG73Details
PRUDENTIAL FINL INCUS74432QBD60Details
PRUDENTIAL FINL INCUS74432QAQ82Details
PRUDENTIAL FINL INCUS74432QAK13Details
PRUDENTIAL FINL INCUS74432QAH83Details
US74432QCH65US74432QCH65Details
PRUDENTIAL FINANCIAL INCUS74432QCF00Details
US74432QCG82US74432QCG82Details
US74432QCJ22US74432QCJ22Details
PRUDENTIAL FINL INCUS74432QCD51Details
PRUDENTIAL FINL INCUS74432QCC78Details
PRUDENTIAL FINANCIAL INCUS74432QCE35Details
PRUDENTIAL FINL INCUS74432QCA13Details
PRUDENTIAL FINL INCUS74432QBY08Details
PRUDENTIAL FINL INCUS74432QBN43Details
PRUDENTIAL FINL INCUS74432QBQ73Details
PRUDENTIAL FINL INCUS74432QBS30Details
PRUDENTIAL FINL INCUS74432AH860Details
US74432AH605US74432AH605Details
US74432AZE36US74432AZE36Details
US74432AZD52US74432AZD52Details
US74432AZB96US74432AZB96Details
PRUDENTIAL FINL INCUS74432AZC79Details
PRUDENTIAL FINL INCUS74432AYX26Details
PRUDENTIAL FINL INCUS74432AYV69Details
PRUDENTIAL FINL INCUS74432AYY09Details
PRUDENTIAL FINL INCUS74432AYZ73Details
US74432AH944US74432AH944Details
PRUDENTIAL FINL INCUS74432AJ270Details
MPLX LP 4875US55336VAG59Details
MPLX LP 4125US55336VAK61Details
MPLX LP 52US55336VAL45Details
Morgan Stanley 3591US61744YAK47Details
Morgan Stanley 3971US61744YAL20Details

Understaning Psychemedics Use of Financial Leverage

Psychemedics' financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Psychemedics' total debt position, including all outstanding debt obligations, and compares it with Psychemedics' equity. Financial leverage can amplify the potential profits to Psychemedics' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Psychemedics is unable to cover its debt costs.
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts. Psychemedics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.
Please read more on our technical analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Psychemedics is a strong investment it is important to analyze Psychemedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psychemedics' future performance. For an informed investment choice regarding Psychemedics Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
(0.51)
Revenue Per Share
3.586
Quarterly Revenue Growth
(0.15)
Return On Assets
(0.16)
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.